Better Therapeutics (BTTX) executive Karbe received 62,500 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Frank Karbe (executive at Better Therapeutics Inc., BTTX) reported that they received 62,500 shares on Dec 18, 2023. After these transactions the filing shows 526,516 shares held directly.
- Reporting person
- Karbe Frank
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 18, 2023 | Grant or award (A) | Common Stock1, 2 | +62,500 | - | - | 526,516 direct |
Holdings before and after
- Common Stock: 464,016 to 526,516 direct
Footnotes from the filing
- 1. The Reporting person was awarded 62,500 Restricted Stock Units ( RSUs ). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
- 2. Includes 34,587 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Karbe report in this BTTX Form 4?
Frank Karbe (executive at Better Therapeutics Inc., BTTX) reported that they received 62,500 shares on Dec 18, 2023. After these transactions the filing shows 526,516 shares held directly.
How many BTTX shares does Karbe hold after this filing?
The filing shows 526,516 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for BTTX
Earlier insider filings at BTTX
- Dec 20, 2023Berman Mark A. was granted 25,362 shares, increasing direct ownership by 6% to 448,140 units (SEC Form 4)
- Jul 31, 2023SEC Form 4: Perry David P bought $900,000 worth of shares (1,233,045 units at $0.73)
- Jul 31, 2023SEC Form 4: Berman Mark A. bought $40,000 worth of shares (54,802 units at $0.73), increasing direct ownership by 16% to 388,191 units
- Jul 31, 2023SEC Form 4: Armanino Andrew J. bought $200,000 worth of shares (274,010 units at $0.73)
- Jul 31, 2023SEC Form 4: Karbe Frank bought $100,000 worth of shares (137,005 units at $0.73), increasing direct ownership by 47% to 429,429 units
Quantisnow market dataNASDAQ
BTTX
Better Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for BTTX
Full BTTX profile on Quantisnow Follow BTTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time